STEP 1 — MCQs (NO answers here)

MCQ 1 — Central Role of Endothelium

The overall effect on clot formation vs dissolution is most directly determined by:

a. Platelet count alone

b. Fibrinogen level alone

c. Balance of endothelial anticoagulant vs procoagulant activities

d. Factor VIII level

e. Number of red cells

MCQ 2 — Normal Endothelium Function

In its normal (intact) state, endothelium primarily:

a. Promotes systemic thrombosis

b. Inhibits platelets and coagulation and enhances fibrinolysis

c. Produces tissue factor constitutively into the blood

d. Activates factor VII directly

e. Stimulates megakaryocyte proliferation

MCQ 3 — Platelet Barrier Function

An obvious antithrombotic function of intact endothelium is:

a. Increasing collagen exposure

b. Shielding platelets from subendothelial vWF and collagen

c. Releasing ADP into the bloodstream

d. Secreting thromboxane A2

e. Producing factor VIII

MCQ 4 — Platelet Inhibitors Released by Endothelium

Which combination inhibits platelet activation/aggregation?

a. Thromboxane A2 and ADP

b. Prostacyclin (PGI2), nitric oxide (NO), and adenosine diphosphatase

c. Endothelin and serotonin

d. Fibrin and vWF

e. Collagen and epinephrine

MCQ 5 — Role of Endothelial Adenosine Diphosphatase

Endothelial adenosine diphosphatase mainly:

a. Converts fibrin to fibrinogen

b. Degrades ADP, reducing platelet activation

c. Activates platelets

d. Activates protein C

e. Produces thromboxane A2

MCQ 6 — Thrombin Handling by Endothelium

Normal endothelium modifies thrombin such that:

a. Thrombin activity is enhanced toward fibrin formation

b. Thrombin becomes a more potent platelet activator

c. Thrombin can be bound and lose its procoagulant and platelet-activating role

d. Thrombin is converted to fibrinogen

e. Thrombin is stored in granules

MCQ 7 — Thrombomodulin–Protein C System

Thrombomodulin and endothelial protein C receptor:

a. Activate factor VII

b. Bind thrombin and protein C, leading to activation of protein C

c. Bind fibrinogen and vWF

d. Activate platelets directly

e. Degrade t-PA

MCQ 8 — Activated Protein C/Protein S Complex

The activated protein C/protein S complex primarily:

a. Activates factors V and VIII

b. Inhibits factors Va and VIIIa

c. Promotes fibrin crosslinking

d. Activates factor XIII

e. Stimulates platelet aggregation

MCQ 9 — Heparin-like Molecules and Antithrombin III

Heparin-like molecules on endothelial surfaces:

a. Inhibit antithrombin III

b. Activate antithrombin III, which inhibits thrombin and factors IXa, Xa, XIa, XIIa

c. Only bind fibrin

d. Activate factor VII directly

e. Block protein C activation

MCQ 10 — Clinical Use of Heparin

The clinical usefulness of heparin is mainly due to:

a. Direct degradation of fibrin

b. Stimulation of antithrombin III activity

c. Inhibition of t-PA synthesis

d. Blocking of protein S

e. Inhibition of collagen exposure

MCQ 11 — Tissue Factor Pathway Inhibitor (TFPI)

TFPI:

a. Activates factor VII

b. Requires protein C as a cofactor

c. Requires protein S and inhibits tissue factor–factor VIIa complexes

d. Only acts on fibrin

e. Activates platelets

MCQ 12 — Endothelium and Fibrinolysis

A key fibrinolytic factor produced by normal endothelium is:

a. Thromboxane A2

b. Tissue plasminogen activator (t-PA)

c. Factor XIII

d. Protein S

e. Endothelin

MCQ 13 — Injury or Inflammatory Activation of Endothelium

When endothelium is injured or exposed to proinflammatory factors, it:

a. Gains more antithrombotic properties

b. Loses many antithrombotic properties and becomes more procoagulant

c. Completely stops interacting with platelets

d. No longer expresses any receptors

e. Cannot produce cytokines

STEP 2 — ANSWERS + SHORT EXPLANATIONS

MCQ 1 — c

Thrombus behavior is determined by the balance of endothelial anticoagulant vs procoagulant functions.

MCQ 2 — b

Normal endothelium:

• Inhibits platelets
• Suppresses coagulation
• Promotes fibrinolysis

MCQ 3 — b

Intact endothelium physically shields platelets from subendothelial vWF and collagen, preventing inappropriate activation.

MCQ 4 — b

Key platelet inhibitors from endothelium:

• PGI2 (prostacyclin)
• NO
• Adenosine diphosphatase (degrades ADP).

MCQ 5 — b

Adenosine diphosphatase degrades ADP, which is a potent activator of platelet aggregation.

MCQ 6 — c

Endothelial binding of thrombin (e.g., via thrombomodulin) causes it to lose its procoagulant/platelet-activating role and redirect toward protein C activation.

MCQ 7 — b

Thrombomodulin binds thrombin, endothelial protein C receptor binds protein C → thrombin then activates protein C instead of fibrin formation.

MCQ 8 — b

Activated protein C + protein S complex is a potent inhibitor of factors Va and VIIIa, down-regulating the cascade.

MCQ 9 — b

Heparin-like molecules bind and activate antithrombin III, which inhibits:

• Thrombin
• Factors IXa, Xa, XIa, XIIa.

MCQ 10 — b

Heparin’s clinical effect = enhances antithrombin III, giving strong anticoagulant action.

MCQ 11 — c

TFPI:

• Requires protein S as cofactor.
• Binds and inhibits tissue factor–factor VIIa complexes.

MCQ 12 — b

Normal endothelium synthesizes t-PA, a major fibrinolytic enzyme activator.

MCQ 13 — b

Injury/proinflammatory activation → endothelium loses antithrombotic properties and shifts toward procoagulant behavior.

STEP 3 — HIGH-YIELD NOTES (EXAM-READY)

Normal Endothelium: The Body’s Built-In Antithrombotic Shield

1. Central Concept

• Endothelium acts as the master regulator of hemostasis.
• Final outcome (no clot / clot / clot removal) depends on balance between:
• Antiplatelet
• Anticoagulant
• Fibrinolytic

functions of normal endothelium

vs

Procoagulant behavior of injured/inflamed endothelium.

2. Antithrombotic Functions of Normal Endothelium

A. Platelet Inhibitory Effects

1. Physical Barrier

• Intact endothelial surface prevents platelet contact with:
• Subendothelial collagen
• vWF
• → Prevents unwanted adhesion.

2. Chemical Platelet Inhibitors

Endothelium continuously releases:

• PGI₂ (Prostacyclin)
• Vasodilator
• Strong inhibitor of platelet aggregation
• NO (Nitric Oxide)
• Vasodilator
• Prevents platelet activation
• Adenosine diphosphatase (ADP ase)
• Degrades ADP, a potent platelet activator→ Reduces platelet recruitment.

3. Thrombin Modulation

• Endothelium binds thrombin, altering its function:
• ↓ Loss of its platelet-activating and procoagulant role
• ↑ Facilitates protein C activation instead.

B. Anticoagulant Effects

1. Physical Shielding

• Prevents coagulation factors from contacting tissue factor in vessel wall.

Key Anticoagulant Pathways

i. Thrombomodulin–Protein C System

• Thrombomodulin binds thrombin → modifies thrombin activity.
• Endothelial protein C receptor binds protein C.
• The complex activates protein C, rather than activating coagulation.
• Activated protein C + protein S:
• Inactivate Va and VIIIa

→ Slows down coagulation cascade.

ii. Heparin-like Molecules & Antithrombin III

• Endothelial heparin-like molecules enhance antithrombin III.
• Antithrombin III inhibits:9,10,11,12,thrombin
• Thrombin
• IXa
• Xa
• XIa
• XIIa
• Clinical link:

Heparin therapy works by boosting antithrombin III.

iii. Tissue Factor Pathway Inhibitor (TFPI)

• Requires protein S as cofactor.
• Inhibits TF–VIIa complex.
• Controls extrinsic pathway activation.

C. Fibrinolytic Effects

• Endothelium secretes t-PA (tissue plasminogen activator).
• Converts plasminogen → plasmin (preferentially on fibrin clots).
• Plasmin:
• Breaks down fibrin
• Limits clot size
• Promotes clot dissolution

3. When Endothelium Becomes Prothrombotic

• Injury / inflammation causes endothelium to:
• Lose antithrombotic traits
• Gain procoagulant behaviors, including:
• ↑ Tissue factor production
• ↑ Platelet-activation signals
• Drives thrombosis (covered later in the hemostasis section).